Henry Schein

Henry Schein. As a leading provider of health care products and services, Henry Schein has established itself as a key player in the medical technology industry, working with companies like Johnson & Johnson, Pfizer, and Merck & Co.. With a strong presence in the United States, Europe, and Asia, Henry Schein has built relationships with organizations such as the American Dental Association, American Medical Association, and the World Health Organization. Through its partnerships with Becton Dickinson, Cardinal Health, and McKesson Corporation, Henry Schein has expanded its reach and offerings.

● History

The company was founded in 1932 by Henry Schein, and over the years, it has undergone significant transformations, including the appointment of Stanley M. Bergman as CEO in 1989, who previously worked at Bristol-Myers Squibb and Warner-Lambert. During this period, Henry Schein acquired several companies, including Sullivan Dental, Darby Dental Supply, and Accord Dental Supply, to expand its product portfolio and geographic reach, similar to the strategies employed by 3M and Stryker Corporation. In the 1990s, Henry Schein began to focus on the dental and medical markets, establishing partnerships with companies like Dentsply Sirona, Ivoclar Vivadent, and Kerr Corporation. This strategic shift enabled the company to capitalize on the growing demand for health care services, driven in part by the Affordable Care Act and the work of organizations like the Centers for Medicare and Medicaid Services and the Food and Drug Administration.

● Products and Services

Henry Schein offers a wide range of products and services, including dental implants from companies like Nobel Biocare and Straumann, medical equipment from GE Healthcare and Philips Healthcare, and practice management software from Epic Systems and Cerner Corporation. The company also provides vaccines and pharmaceuticals from manufacturers like GlaxoSmithKline, Sanofi, and AstraZeneca, as well as medical supplies from Medline Industries and Cardinal Health. Additionally, Henry Schein offers consulting services and training programs to help health care professionals improve their practices, similar to those offered by Deloitte and PricewaterhouseCoopers. Through its partnerships with companies like Microsoft and IBM, Henry Schein has developed innovative solutions to support the health care industry, including telemedicine platforms and electronic health records systems, which have been adopted by organizations like the Department of Veterans Affairs and the National Institutes of Health.

● Corporate Affairs

Henry Schein is headquartered in Melville, New York, and has operations in over 30 countries, including the United States, Canada, Germany, and Australia. The company has established relationships with various health care organizations, such as the American Hospital Association, American Academy of Pediatrics, and the World Medical Association. Henry Schein has also partnered with companies like UnitedHealth Group, Anthem, Inc., and Cigna to provide health care services and solutions. Furthermore, the company has collaborated with academic institutions like Harvard University, Stanford University, and University of California, Los Angeles to advance medical research and education, similar to the initiatives undertaken by National Science Foundation and the Bill and Melinda Gates Foundation.

● Financial Performance

Henry Schein has consistently reported strong financial performance, with revenues exceeding $10 billion in recent years, driven in part by the growth of the global health care market, which has been influenced by factors like the Aging population and the increasing prevalence of chronic diseases. The company's financial success has been recognized by Fortune 500, which has ranked Henry Schein among the largest and most successful companies in the United States, alongside other industry leaders like Johnson & Johnson, Pfizer, and UnitedHealth Group. Henry Schein has also been included in the S&P 500 index, which tracks the performance of the largest publicly traded companies in the United States, including Microsoft, Apple Inc., and Amazon (company).

● Controversies

Like many companies in the health care industry, Henry Schein has faced controversies and challenges, including product recalls and regulatory issues, similar to those experienced by companies like GlaxoSmithKline and Merck & Co.. In 2017, the company faced a class-action lawsuit related to its dental implant business, which was resolved through a settlement with the Federal Trade Commission and the U.S. Department of Justice. Henry Schein has also been criticized for its pricing practices and distribution agreements, which have been the subject of investigations by the European Commission and the U.S. Senate. Despite these challenges, the company has maintained its commitment to corporate social responsibility and sustainability, as recognized by organizations like the Dow Jones Sustainability Index and the United Nations Global Compact.

● Leadership and Governance

Henry Schein is led by a experienced management team, including CEO Stanley M. Bergman and CFO James P. Breslawski, who have previously worked at companies like Bristol-Myers Squibb and Warner-Lambert. The company's board of directors includes prominent health care leaders, such as Dr. Philip Pizzo from Stanford University and Dr. Steven Schroeder from University of California, San Francisco. Henry Schein has also established a corporate governance framework, which includes a code of conduct and a compliance program, to ensure that the company operates with integrity and transparency, similar to the standards set by the Securities and Exchange Commission and the Sarbanes-Oxley Act. Through its leadership and governance structure, Henry Schein has demonstrated its commitment to ethical business practices and social responsibility, as recognized by organizations like the Ethisphere Institute and the World Business Council for Sustainable Development. Category:Health care companies